Dr. David Michael Hyman, MD
- Medicare services, 2019
- 378
- Part D claims, 2019
- 97
- Publications
- 187
- Clinical trials
- 5
- Hospital affiliations
- 1
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Hyman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David Michael Hyman is a medical oncologist in New York, New York
Dr. Hyman practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Hyman's NPI, 1477710556, was assigned on May 17, 2008. Dr. Hyman holds New York license 245748.
- NPI
- 1477710556NPI Registry (opens in a new tab)
- NPI enumeration date
- May 17, 2008
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David Michael Hyman practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Hyman's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. David Michael Hyman is affiliated with 1 site of care and 1 medical group
Dr. Hyman's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center.
Sources: Dmand AI Affiliation Data; Doctors and Clinicians National Downloadable File (CMS); and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. David Michael Hyman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hyman practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David Michael Hyman is one of 458 medical oncologists in New York
Medical oncology is Dr. Hyman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Hyman is licensed in New York.
Specialties and state licenses
- Medical oncology, New YorkPrimary
Medical oncologists near Dr. Hyman
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David Michael Hyman billed Medicare for 378 services in 2019
CMS data shows 378 Medicare services from Dr. Hyman across 2 procedure codes in 2019. Medicare paid $26,948 for them.
Dr. Hyman's Medicare services by type, 2018 to 2019
- 2018
- 2019
- Office and hospital visits
- 2018: 3902019: 3783%
Where Dr. Hyman's Medicare services took place, 2019
- In an office34792%
- In a facility318%
Dr. Hyman compared with the New York median for medical oncologists, 2019
- Dr. Hyman
- New York median
- Medicare services
- 378vs 34011% above
- Part D claims
- 97vs 13025% below
Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Hyman's most billed Medicare procedure codes, 2019
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Hyman?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Hyman and other medical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David Michael Hyman's patients have a median age of 82
Across all payers, Dmand AI patient panel data puts Dr. Hyman's median patient age at 82, with 100% women.
Dr. Hyman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 82
Patient panel by sex, all payers
- Women100%
- Men0%
Source: Dmand AI Patient Panel Data
Dr. David Michael Hyman wrote 97 Medicare Part D claims in 2019
In 2019, Dr. Hyman wrote 97 Medicare Part D claims. They cover 6 drugs, with $9,744 in total drug cost. In 2018, CMS named 136 claims across 6 drugs.
Dr. Hyman's most prescribed drugs by claims, 2019
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2018 to 2019
- 2018
- 2019
- Claims for drugs CMS names
- 2018: 1362019: 9729%
Drugs named by CMS: 6 in 2019, 6 in 2018.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David Michael Hyman has 187 publications on record
Dmand AI links 187 papers to Dr. Hyman, published from 2011 to 2024. 2018 was the busiest year, with 26. The most frequent topics are Antineoplastic Agents, Biomarkers, Tumor and Molecular Targeted Therapy. Dr. Hyman has published most often in Clin Cancer Res. Dr. Hyman's most frequent co-authors are Jaclyn Frances Hechtman, MD, Mark E. Robson, MD and Eli Louis Diamond, MD.
Dr. Hyman's papers by year, 2015 to 2024
Topics Dr. Hyman writes about most
- Antineoplastic Agents
- Biomarkers, Tumor
- Molecular Targeted Therapy
- Genomics
- Precision Medicine
- Protein Kinase Inhibitors
- High-Throughput Nucleotide Sequencing
- Breast Neoplasms
Dr. Hyman's most frequent co-authors
- Jaclyn Frances Hechtman, MD21 shared papers
- Mark E. Robson, MD21 shared papers
- Eli Louis Diamond, MD19 shared papers
Recent publications by Dr. Hyman
Pancreaticoduodenectomy After Liver Transplantation: A Single-Center Experience (opens in a new tab)
World J Surg
Nat Commun
See who Dr. Hyman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hyman works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David Michael Hyman has worked on 5 clinical trials
Dmand AI links Dr. Hyman to 5 clinical trials, 2 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Hematologic Neoplasms and Prostatic Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 2.
Clinical trials with Dr. Hyman by phase
- 2Phase 1: 2 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Hyman's trials
- Fallopian Tube Diseases
- Hematologic Neoplasms
- Prostatic Neoplasms
- Thyroid Neoplasms
- Fallopian Tube Neoplasms
Investigators on the most trials with Dr. Hyman
- Ovadia Abulafia, MD1 shared trial
- Bamidele A. Adesunloye, MD1 shared trial
- Christian S. Adonizio, MD1 shared trial
Recent clinical trials with Dr. Hyman
A Pilot Study of AZD5363 for Patients With Advanced Solid Tumors Harboring Mutations in AKT1, AKT2, or AKT3 (opens in a new tab)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (opens in a new tab)
Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. David Michael Hyman received $43,235 in industry payments from 2016 to 2023
CMS Open Payments shows 63 general payments to Dr. Hyman from 11 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 58% of the total. Genentech, Inc. paid the most, $28,208. It also lists 4 research payments totaling $29,745 from 2018 to 2020.
General payments to Dr. Hyman by program year, 2016 to 2023
General payments to Dr. Hyman by kind, 2016 to 2023
- Consulting fees$25,22858%
- Travel and lodging$13,92832%
- Food and beverage$2,4046%
- Speaker and faculty fees$1,6764%
Companies that paid Dr. Hyman the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. David Michael Hyman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Dmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David Michael Hyman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David Michael Hyman's NPI number?
Dr. David Michael Hyman's NPI number is 1477710556. It was assigned on May 17, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. David Michael Hyman?
Dr. David Michael Hyman is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. David Michael Hyman practice?
Dr. Hyman practices at 1275 York Avenue, New York, NY 10065. Dr. Hyman's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
What is Dr. David Michael Hyman's medical license number?
Dr. Hyman holds New York license 245748.
Which hospitals is Dr. David Michael Hyman affiliated with?
Dr. Hyman practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. David Michael Hyman part of?
Dr. Hyman is linked to Memorial Sloan Kettering Cancer Center.
Does Dr. David Michael Hyman accept Medicare?
Yes. CMS data shows Dr. Hyman billed Medicare for 378 services in 2019.
What services does Dr. David Michael Hyman bill to Medicare?
In 2019, Dr. Hyman's most billed Medicare services were office visit, established patient (99214) and hospital inpatient care (99233).
What drugs does Dr. David Michael Hyman prescribe most?
In 2019 Medicare Part D data, Dr. Hyman's most prescribed drugs by claims were Dexamethasone, Ondansetron HCl and Xarelto.
Has Dr. David Michael Hyman received payments from drug or device companies?
CMS Open Payments shows $43,235 in general payments to Dr. Hyman from 11 companies from 2016 to 2023. The largest total came from Genentech, Inc.
Show 3 more questionsShow fewer questions
How long has Dr. David Michael Hyman been practicing?
Dr. Hyman's NPI was assigned in 2008.
Does Dr. David Michael Hyman do research?
Dmand AI links 187 publications to Dr. Hyman, published from 2011 to 2024. Dr. Hyman has worked on 5 clinical trials.
Who does Dr. David Michael Hyman publish with?
Dr. Hyman's most frequent co-authors are Jaclyn Frances Hechtman, MD (21 shared papers), Mark E. Robson, MD (21 shared papers) and Eli Louis Diamond, MD (19 shared papers).
Selling to medical oncology practices?
See medical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card